The influence of leptin on trabecular architecture and marrow adiposity in GH-deficient rats

Journal of Endocrinology

Volumn 208, Issue 1, 2011, Pages 69-79

  Evans, Bronwen A J ^b   Bull, Melanie J ^a   Kench, Rebecca C ^a   Fox, Rebecca E ^a   Morgan, Liam D ^b   Stevenson, Amy E ^a   Gevers, Evelien F ^c   Perry, Mark J ^d   Wells, Timothy ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GROWTH HORMONE; LEPTIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW; BONE STRUCTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; EPIPHYSIS PLATE; FEMALE; GROWTH HORMONE DEFICIENCY; HYPERLEPTINEMIA; IMMUNOREACTIVITY; MALE; NONHUMAN; OBESITY; OSTEOCLAST; PRIORITY JOURNAL; RAT; TRABECULAR BONE; WILD TYPE;

ADIPOCYTES; ADIPOSITY; ANALYSIS OF VARIANCE; ANIMALS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; GROWTH HORMONE; LEPTIN; MALE; OSTEOBLASTS; OSTEOCLASTS; RADIOIMMUNOASSAY; RATS;

EID: 78650972865     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-10-0178     Document Type: Article

References (48)

1. Bouillon R 1991 Growth hormone and bone. Hormone Research 36 49-55. (doi:10.1159/000182189)
2. Charlton HM, Clark RG, Robinson ICAF, Porter Goff AE, Cox BS, Bugnon C & Bloch BA 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. Journal of Endocrinology 119 1-58. (doi:10.1677/joe.0.1190051)
3. Davies JS, Thompson NM, Christian HC, Pinilla L, Ebling FJP, Tena-Sempere M & Wells T 2006 Hypothalamic expression of human growth hormone induces post pubertal hypergonadotrophism in male transgenic growth retarded (Tgr) rats. Journal of Neuroendocrinology 18 719-731. (doi:10.1111/j.1365-2826.2006.01467. x)
4. Davies JS, Gevers EF, Stevenson AE, Coschigano KT, El-Kasti MM, Bull MJ, Elford C, Evans BAJ, Kopchick JJ & Wells T 2007 Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency. American Journal of Physiology. Endocrinology and Metabolism 292 E1483-E1494. (doi:10.1152/ajpendo.00417.2006)
5. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM & Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 197-207. (doi:10.1016/S0092-8674(00)81558-5)
6. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P & Pottie P 2003 Evidence for a key role of leptin in osteoarthritis. Arthritis and Rheumatism 48 3118-3129. (doi:10.1002/art.11303)
7. Evans BAJ,Warner JT, Elford C, Evans SL, Laib A, Bains RK, Gregory JW & Wells T 2003 Morphological determinants of femoral strength in growth hormone-deficient transgenic growth retarded (Tgr) rats. Journal of Bone and Mineral Research 18 1308-1316. (doi:10.1359/jbmr.2003.18.7.1308)
8. Fisker S, Vahl N, Hansen TB, Jørgenson JO, Hagen C, Orskov H & Christiansen JS 1997 Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebocontrolled growth hormone therapy for 1 year. Metabolism 46 812-817. (doi:10.1016/S0026-0495(97) 90128-1)
9. Flavell DM, Wells T, Wells SE, Carmignac DF, Thomas GB & Robinson ICAF 1996 A new dwarf rat: dominant negative phenotype in GRF-GH transgenic growth retarded (Tgr) rats. EMBO Journal 15 3871-3879.
10. Frost HM & Jee WS 1992 On the rat model of human osteopenias and osteoporoses. Bone and Mineral 18 227-236. (doi:10.1016/0169-6009(92)90809-R)
11. Gat-Yablonski G, Shtaif B & Phillip M 2007 Leptin stimulates parathyroid hormone related peptide expression in the endochondrial growth plate. Journal of Pediatric Endocrinology and Metabolism 20 1215-1222.
12. Gevers EF, Loveridge N & Robinson ICAF 2002 Bone marrow adipocytes: a neglected target for growth hormone. Endocrinology 143 4065-4073. (doi:10.1210/en.2002-220428)
13. Growth Hormone Research Society 2000 Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. Journal of Clinical Endocrinology and Metabolism 85 3990-3993. (doi:10.1210/jc.85.11.3990)
14. Guidobono F, Pagani F, Sibilia V, Netti C, Lattuada N, Rapetti D, Mrak E, Villa I, Cavani F, Bertoni L et al. 2006 Different skeletal regional response to continuous brain infusion of leptin in the rat. Peptides 27 1426-1433. (doi:10.1016/j.peptides.2005.10.014)
15. Hamrick MW & Ferrari SL 2007 Leptin and the sympathetic connection of fat to bone. Osteoporosis International 19 905-912. (doi:10.1007/s00198-007- 0487-9)
16. Hamrick MW, Pennington C, Newton D, Xie D & Isales C 2004 Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34 376-383. (doi:10.1016/j.bone.2003.11.020) (Pubitemid 38314902)
17. Hamrick MW, Della-Fera MA, Choi Y-H, Pennington C, Hartzell D & Baile CA 2005 Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. Journal of Bone and Mineral Research 20 994-1001. (doi:10.1359/JBMR.050103)
18. Hamrick MW, Della-Fera MA, Choi YH, Hartzell D, Pennington C & Baile CA 2007 Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow. Cell and Tissue Research 327 133-141. (doi:10.1007/s00441-006-0312-3)
19. Holmes SJ, Economou G, Whitehouse RW, Adams JE & Shalet SM 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 78 669-674. (doi:10.1210/jc.78.3.669)
20. Hurley MM, Kream BE & Raisz LG 1990 Structural determinants of the capacity of heparin to inhibit collagen synthesis in 21-day fetal calvariae. Journal of Bone and Mineral Research 5 1127-1133. (doi:10.1002/jbmr.5650051106)
21. Iwaniec UT, Boghossian S, Lapke PD, Turner RK & Kalra SP 2007 Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice. Peptides 28 1012-1019. (doi:10.1016/j.peptides.2007.02.001)
22. Jørgenson JO, Vahl N, Hansen TB, Fisker S, Hagen C & Christiansen JS 1996 Influence of growth hormone and androgens on body composition in adults. Hormone Research 45 94-98. (doi:10.1159/000184766)
23. Kishida Y, Hirao M, Tamai N, Nampei A, Fujimoto T, Nakase T, Shimizu N, Yoshikawa H & Myoui A 2005 Leptin regulates chondrocyte differentiation and matrix formation during endochondrial ossification. Bone 37 607-621. (doi:10.1016/j.bone.2005.05.009)
24. Laharrague P, Larrouy D, Fontanilles A-M, Truel N, Campfield A, Tenenbaum R, Galitzky J, Corberand JX, Pénicaud L & Casteilla L 1998 High expression of leptin by human bone marrow adipocytes in primary culture. FASEB Journal 12 747-752.
25. Lee Y-J, Park J-H, Ju S-K, You K-H, Ko JS & Kim H-M 2002 Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Letters 528 43-47. (doi:10.1016/S0014-5793(02)02889-2)
26. Legraverend C, Mode A, Wells T, Robinson IC & Gustafsson JÅ 1992 Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. FASEB Journal 6 711-718.
27. Martin A, David V, Malaval L, Lafage-Proust M-H, Vico L & Thomas T 2007 Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinology 148 3419-3425. (doi:10.1210/en.2006-1541)
28. Muruganandan S, Roman AA & Sinal CJ 2009 Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cellular and Molecular Life Sciences 66 236-253. (doi:10.1007/s00018-008-8429-z)
29. Nakajima R, Inada H, Koike T & Yamano T 2003 Effects of leptin to cultured growth plate chondrocytes. Hormone Research 60 91-98. (doi:10.1159/000071877)
30. Núñez NP, Carpenter CL, Perkins SN, Berrigan D, Jaque SV, Ingles SA, Bernstein L, Forman MR, Barrett JC & Hursting SD 2007 Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity 15 1980-1987. (doi:10.1038/oby.2007.236)
31. Ohlsson C, Bengtsson B-Å, Isaksson OGP, Andreasson TT & Slootweg MC 1998 Growth hormone and bone. Endocrine Reviews 19 55-79. (doi:10.1210/er.19.1.55)
32. Osip SL, Butcher M, Young E, Yang L & Shaughnessy SG 2004 Differential effects of heparin and low molecular weight heparin on osteoblastogenesis and adipogenesis in vitro. Thrombosis and Haemostasis 92 803-810.
33. Qian H, Azain MJ, Compton MM, Hartzell DL, Hausman GJ & Baile CA 1998 Brain administration of leptin causes deletion of adipocytes by apoptosis. Endocrinology 139 791-794. (doi:10.1210/en.139.2.791)
34. Raine JE, Donaldson MDC, Gregory JW, Savage MO & Hintz RL 2006 Short Stature. In: Practical Endocrinology and Diabetes in Children, pp 42-64. Oxford: Blackwell Publishing.
35. Rosén T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G & Bengtsson B-Å 1997 Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. European Journal of Endocrinology 137 240-245. (doi:10.1530/eje.0.1370240)
36. Sabovich I, Clark JD, Liao G, Peltz G, Lindsey DP, Jacobs CR, Yao W, Guo T-Z & Kingery WS 2008 Bone microstructure and its associated genetic variability in 12 inbred mouse strains: μCT study and in silico genome scan. Bone 42 439-451. (doi:10.1016/j.bone.2007.09.041)
37. Samuels A, Perry MJ & Tobias JH 1999 High-dose estrogen induces medullary bone formation in female mice. Journal of Bone and Mineral Research 14 178-186. (doi:10.1359/jbmr.1999.14.2.178)
38. Shibli-Rahhal A & Schlechte J 2009 The effects of hyperprolactinemia on bone and fat. Pituitary 12 96-104. (doi:10.1007/s11102-008-0097-3)
39. Steppan CM, Crawford DT, Chidsey-Frink KL, Ke HZ & Swick AG 2000 Leptin is a potent stimulator of bone growth in ob/ob mice. Regulatory Peptides 92 73-78. (doi:10.1016/S0167-0115(00)00152-X)
40. Stevenson AE, Evans BAJ, Gevers EF, Elford C, McLeod RJ, Perry M, El-Kasti MM, Coschigano KT, Kopchick JJ, Evans SL et al. 2009 Does adiposity status influence femoral cortical strength in rodent models of growth hormone-deficiency? American Journal of Physiology. Endocrinology and Metabolism 296 E147-E156. (doi:10.1152/ajpendo.90689.2008)
41. Still K, Grabowski P, Mackie I, Perry M & Bishop N 2008 The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo. Calcified Tissue International 83 285-292. (doi:10.1007/s00223-008-9175-9)
42. Tannenbaum GS, Gurd W & Lapointe M 1998 Leptin is a potent stimulator of spontaneous pulsatile growth hormone (GH) secretion and the GH response to GH-releasing hormone. Endocrinology 139 3871-3875. (doi:10.1210/en.139.9.3871)
43. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B & Riggs BL 1999 Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140 1630-1638. (doi:10.1210/en.140.4.1630)
44. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson ICAF &Wells T 2004 Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145 234-242. (doi:10.1210/en.2003-0899)
45. Venken K, Movérare-Skrtic S, Kopchick JJ, Coschigano KT, Ohlsson C, Boonen S, Bouillon R & Vanderschueren D 2007 Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty. Journal of Bone and Mineral Research 22 72-82. (doi:10.1359/jbmr.060911) (Pubitemid 46032599)
46. Wells T 2009 Ghrelin - defender of fat. Progress in Lipid Research 48 275-297. (doi:10.1016/j.plipres.2009.04.002)
47. Wells T, Flavell DM, Wells SE, Carmignac DF & Robinson ICAF 1997 Effects of GH secretagogues in the transgenic growth retarded (Tgr) rat. Endocrinology 138 580-587. (doi:10.1210/en.138.2.580)
48. Yarram SJ, Perry MJ, Christopher TJ, Westby K, Brown NL, Lamminen T, Rulli SB, Zhang FP, Huhtaniemi I, Sandy JR et al. 2003 Luteinizing hormone receptor knockout (LuRKO) mice and transgenic human chorionic gonadotropin (hCG)-overexpressing mice (hCG αβ+) have bone phenotypes. Endocrinology 144 3555-3564. (doi:10.1210/en.2003-0036)